Skip to content

Exablate 2000 System

by Insightec Ltd

PMA P040003

Active United States

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

PMA P040003↗

FDA record

Trust

Unverified

Source FDA PMA, synced 6 Oct 2026.

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPPR Approved NumberP040003 Date22 Oct 2004ApprovedStatusActive

Official records

From the FDA record

FDA PMA P040003

Received by the FDA
27 Jan 2004
FDA decision
22 Oct 2004
FDA review time
269 days from receipt to decision
Expedited review
Yes
Docket number
05M-0473
Approval order statement, verbatim
APPROVAL FOR THE EXABLATE 2000 SYSTEM. THE DEVICE IS INDICATED FOR ABLATION OF UTERINE FIBROID TISSUE IN PRE-OR PERI-MENOPAUSAL WOMEN WITH SYMPTOMATIC UTERINE FIBROIDS WHO DESIRE A UTERINE SPARING PROCEDURE. PATIENTS MUST HAVE A UTERINE SIZE OF LESS THAN 24 WEEKS AND HAVE COMPLETED CHILD BEARING.

From the FDA PMA record P040003 (openFDA), as read on 6 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

PMA

Full name
Exablate 2000 System Magnetic Resonance Guided Focused Ultrasound Ablation of Uterine Fibroids
Trade name
Exablate 2000 System
Generic name
Ablation system, high intensity focused ultrasound (HIFU), MR-guided
FDA applicant
Insightec, Ltd.
PMA number
FDA product code
NRZ
Device class
Class III
Advisory committee
Obstetrics/Gynecology
FDA decision
APPR Approved

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Exablate 2000 System is an MR-guided high intensity focused ultrasound (HIFU) ablation system. It is indicated for the ablation of uterine fibroid tissue in pre- or peri-menopausal women with symptomatic uterine fibroids who desire a uterine-sparing procedure.

Patients must have a uterine size of less than 24 weeks and have completed child bearing. The system received FDA PMA approval (P040003) and is classified as a Class III device under product code NRZ. It is manufactured by Insightec Ltd and supplied as a non-sterile, reusable system for use in clinical MRI environments.

Devices cleared under P040003

1 device · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under P040003
UDI-DISize and differences
Patient accessory kit for Body
INSIGHTEC LTD
SET000016 / Patient accessory kit for Body07290015461047 —On the market

Similar devices

Other devices filed under FDA product code NRZ (Ablation System, High Intensity Focused Ultrasound (Hifu), Mr-Guided).

Other devices from Insightec Ltd

See all devices from Insightec Ltd →